A Phase 1, Two-Part, Open-label Study in Healthy Adult Volunteers to Assess a Single Dose of Vadadustat as a Victim in Drug-Drug Interactions With Cyclosporine, Probenecid and Rifampin
Latest Information Update: 08 May 2021
At a glance
- Drugs Ciclosporin (Primary) ; Probenecid (Primary) ; Rifampicin (Primary) ; Vadadustat (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Akebia Therapeutics
Most Recent Events
- 25 Mar 2021 According to an Akebia Therapeutics media release, data from this trial will be presented at the National Kidney Foundation 2021 Spring Clinical Meetings (NKF SCM21),
- 28 Mar 2019 Last check against ClinicalTrials.gov: US National Institutes of Health
- 20 Mar 2019 Status changed from active, no longer recruiting to completed.